Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures.

Isabella McCaryChristine J Guelcher Janice KuhnRegina ButlerGita MasseyMichael F GuerreraLance BallesterLeslie Raffini

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)

Our favourable clinical experience with emicizumab is similar to that reported in the clinical trials. Notably, this is the largest cohort of patients <12 years without inhibitors treated with emicizumab.

Keyphrases

clinical trial
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
randomized controlled trial
type diabetes
adipose tissue
phase ii